Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies

Adv Ther. 2024 May 18. doi: 10.1007/s12325-024-02894-x. Online ahead of print.

Authors

Affiliations

¹ Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
² Analysis Group Inc., New York, NY, USA.
³ Analysis Group Inc., Boston, MA, USA.
⁴ Gamida Cell Inc., Boston, MA, USA.
⁵ Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu.

PMID: 38762585
DOI: 10.1007/s12325-024-02894-x

No abstract available

Publication types

Published Erratum